You are here

Newsroom

Coronavirus Top News

Press Release | September 22, 2020
WASHINGTON, D.C. – As part of the medtech industry’s ongoing mobilization to combat COVID-19, the Advanced Medical Technology Association (AdvaMed) today announced that the U.S. Agency for International Development (USAID) has approved a multi-year partnership under which the association will provide private sector resources and expertise to help increase adoption of medical technology-specific international regulatory standards and good regulatory practices by governments across Latin America, Africa, and Southeast Asia.
Press Release | September 17, 2020
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today announced that total U.S. shipments of COVID-19 molecular diagnostic tests have reached more than 150 million, based on the latest data from the association’s COVID-19 testing supply registry.
Press Release | August 20, 2020
WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement: “AdvaMed fully supports policies that foster innovation and regulatory flexibility to speed quality tests to patients. This principle is core to the industry’s long-standing call for a modernization of the regulatory framework for all diagnostic tests, both commercial in vitro diagnostics (IVDs) developed and manufactured by AdvaMed members, and laboratory developed tests (LDTs)."
 

Top News

Press Release | September 30, 2020
LOS ANGELES, CA – MedTech Innovator, the largest accelerator of medical devices in the world, and AdvaMed Accel, the leading advocacy association for emerging medtech firms, today announced that Vena Vitals has been awarded the 2020 MedTech Innovator Execution Award and the Virginia Shimer Rybski Memorial Award.
Press Release | September 28, 2020
WASHINGTON, D.C.– The life-changing impact of medical technologies on individuals’ lives is the story during Week 4 of The Virtual MedTech Conference, powered by AdvaMed, with the opening of this year’s Patient Pavilion.
Press Release | September 23, 2020
WASHINGTON, D.C. – New data from AdvaMed’s COVID-19 Diagnostic Supply Registry reveals that total U.S. shipments of COVID-19 molecular diagnostic tests have reached 160 million. A breakdown of the data shows that innovative diagnostics companies are shipping, on average, 1.2 million molecular tests each day.

Latest medtech news

Get the latest medtech news. Sign up for AdvaMed SmartBrief, a daily snapshot of medical technology industry news.